Structural basis for isoform-selective inhibition in nitric oxide synthase

Accounts of Chemical Research

Volumn 46, Issue 2, 2013, Pages 390-398

  Poulos, Thomas L ^a   Li, Huiying ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; ISOPROTEIN; NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; RAT;

ANIMALS; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; NITRIC OXIDE SYNTHASE; PROTEIN ISOFORMS; RATS;

EID: 84874072755     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/ar300175n     Document Type: Article

References (44)

1. Goodford, P. J. Drug design by the method of receptor fit J. Med. Chem. 1984, 27, 558-564
2. Walkinshaw, M. D. Protein targets for structure-based drug design Med. Res. Rev. 1992, 12, 317-372
3. Cushman, D. W.; Cheung, H. S.; Sabo, E. F.; Ondetti, M. A. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids Biochemistry 1977, 16, 5484-5491
4. Petsko, G. A. An idea whose time has gone Genome Biol. 2007, 8, 107
5. Wlodawer, A.; Erickson, J. W. Structure-based inhibitors of HIV-1 protease Annu. Rev. Biochem. 1993, 62, 543-585
6. Silverman, R. B. Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases Acc. Chem. Res. 2009, 42, 439-451
7. Hurshman, A. R.; Krebs, C.; Edmondson, D. E.; Huynh, B. H.; Marletta, M. A. Formation of a pterin radical in the reaction of the heme domain of inducible nitric oxide synthase with oxygen Biochemistry 1999, 38, 15689-15696
8. Wei, C. C.; Wang, Z. Q.; Wang, Q.; Meade, A. L.; Hemann, C.; Hille, R.; Stuehr, D. J. Rapid kinetic studies link tetrahydrobiopterin radical formation to heme-dioxy reduction and arginine hydroxylation in inducible nitric-oxide synthase J. Biol. Chem. 2001, 276, 315-319
9. Tzeng, E.; Billiar, T. R.; Robbins, P. D.; Loftus, M.; Stuehr, D. J. Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 11771-11775
10. Crane, B. R.; Arvai, A. S.; Ghosh, D. K.; Wu, C.; Getzoff, E. D.; Stuehr, D. J.; Tainer, J. A. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate Science 1998, 279, 2121-2126
11. Fischmann, T. O.; Hruza, A.; Niu, X. D.; Fossetta, J. D.; Lunn, C. A.; Dolphin, E.; Prongay, A. J.; Reichert, P.; Lundell, D. J.; Narula, S. K.; Weber, P. C. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation Nat. Struct. Biol. 1999, 6, 233-242
12. Li, H.; Raman, C. S.; Glaser, C. B.; Blasko, E.; Young, T. A.; Parkinson, J. F.; Whitlow, M.; Poulos, T. L. Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase J. Biol. Chem. 1999, 274, 21276-21284
13. Raman, C. S.; Li, H.; Martasek, P.; Kral, V.; Masters, B. S.; Poulos, T. L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center Cell 1998, 95, 939-950
14. Garcin, E. D.; Bruns, C. M.; Lloyd, S. J.; Hosfield, D. J.; Tiso, M.; Gachhui, R.; Stuehr, D. J.; Tainer, J. A.; Getzoff, E. D. Structural basis for isozyme-specific regulation of electron transfer in nitric-oxide synthase J. Biol. Chem. 2004, 279, 37918-37927
15. Bredt, D. S.; Snyder, S. H. Nitric oxide: a physiologic messenger molecule Annu. Rev. Biochem. 1994, 63, 175-195
16. Arnold, W. P.; Mittal, C. K.; Katsuki, S.; Murad, F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations Proc. Natl. Acad. Sci. U.S.A. 1977, 74, 3203-3207
17. Calabrese, V.; Mancuso, C.; Calvani, M.; Rizzarelli, E.; Butterfield, D. A.; Stella, A. M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity Nat. Rev. Neurosci. 2007, 8, 766-775
18. Cho, D. H.; Nakamura, T.; Fang, J.; Cieplak, P.; Godzik, A.; Gu, Z.; Lipton, S. A. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury Science 2009, 324, 102-105
19. Endres, M.; Laufs, U.; Liao, J. K.; Moskowitz, M. A. Targeting eNOS for stroke protection Trends Neurosci. 2004, 27, 283-289
20. Hantraye, P.; Brouillet, E.; Ferrante, R.; Palfi, S.; Dolan, R.; Matthews, R. T.; Beal, M. F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons Nat. Med. 1996, 2, 1017-1021
21. Huang, P. L.; Huang, Z.; Mashimo, H.; Bloch, K. D.; Moskowitz, M. A.; Bevan, J. A.; Fishman, M. C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase Nature 1995, 377, 239-242
22. Przedborski, S.; Jackson-Lewis, V.; Yokoyama, R.; Shibata, T.; Dawson, V. L.; Dawson, T. M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 4565-4571
23. Furfine, E. S.; Harmon, M. F.; Paith, J. E.; Garvey, E. P. Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine Biochemistry 1993, 32, 8512-8517
24. Chen, P. F.; Tsai, A. L.; Berka, V.; Wu, K. K. Mutation of Glu-361 in human endothelial nitric-oxide synthase selectively abolishes L-arginine binding without perturbing the behavior of heme and other redox centers J. Biol. Chem. 1997, 272, 6114-6118
25. Silverman, R. B.; Huang, H.; Marletta, M. A.; Martasek, P. Selective inhibition of neuronal nitric oxide synthase by N omega-nitroarginine-and phenylalanine-containing dipeptides and dipeptide esters J. Med. Chem. 1997, 40, 2813-2817
26. Gomez-Vidal, J. A.; Martasek, P.; Roman, L. J.; Silverman, R. B. Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors J. Med. Chem. 2004, 47, 703-710
27. Hah, J. M.; Roman, L. J.; Martasek, P.; Silverman, R. B. Reduced amide bond peptidomimetics. (4S)- N -(4-amino-5-[aminoakyl]aminopentyl)- N ′-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase J. Med. Chem. 2001, 44, 2667-2670
28. Flinspach, M. L.; Li, H.; Jamal, J.; Yang, W.; Huang, H.; Hah, J. M.; Gomez-Vidal, J. A.; Litzinger, E. A.; Silverman, R. B.; Poulos, T. L. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase Nat. Struct. Mol. Biol. 2004, 11, 54-59
29. Ji, H.; Stanton, B. Z.; Igarashi, J.; Li, H.; Martasek, P.; Roman, L. J.; Poulos, T. L.; Silverman, R. B. Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors J. Am. Chem. Soc. 2008, 130, 3900-3914
30. Igarashi, J.; Li, H.; Jamal, J.; Ji, H.; Fang, J.; Lawton, G. R.; Silverman, R. B.; Poulos, T. L. Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors J. Med. Chem. 2009, 52, 2060-2066
31. Ji, H.; Tan, S.; Igarashi, J.; Li, H.; Derrick, M.; Martasek, P.; Roman, L. J.; Vasquez-Vivar, J.; Poulos, T. L.; Silverman, R. B. Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy Ann. Neurol. 2009, 65, 209-217
32. Delker, S. L.; Ji, H.; Li, H.; Jamal, J.; Fang, J.; Xue, F.; Silverman, R. B.; Poulos, T. L. Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model J. Am. Chem. Soc. 2010, 132, 5437-5442
33. Xue, F.; Li, H.; Fang, J.; Roman, L. J.; Martasek, P.; Poulos, T. L.; Silverman, R. B. Peripheral but crucial: a hydrophobic pocket (Tyr(706), Leu(337), and Met(336)) for potent and selective inhibition of neuronal nitric oxide synthase Bioorg. Med. Chem. Lett. 2010, 20, 6258-6261
34. Massova, I.; Kollman, P. A. Computational alanine scanning to probe protein-protein interactions: A novel approach to evaluate binding free energies J. Am. Chem. Soc. 1999, 121, 8133-8143
35. Brown, S. P.; Muchmore, S. W. High-througput calculation of protein-ligand binding affinities: Modification and adaption of the MM-PBSA protocol to enterprise grdi computing J. Chem. Inf. Model. 2006, 46, 999-1005
36. Xue, F.; Fang, J.; Delker, S. L.; Li, H.; Martasek, P.; Roman, L. J.; Poulos, T. L.; Silverman, R. B. Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase J. Med. Chem. 2011, 54, 2039-2048
37. Delker, S. L.; Xue, F.; Li, H.; Jamal, J.; Silverman, R. B.; Poulos, T. L. Role of zinc in isoform-selective inhibitor binding to neuronal nitric oxide synthase Biochemistry 2010, 49, 10803-10810
38. Rao, S.; Lin, Z.; Drobyshevsky, A.; Chen, L.; Ji, X.; Ji, H.; Yang, Y.; Yu, L.; Derrick, M.; Silverman, R. B.; Tan, S. Involvement of neuronal nitric oxide synthase in ongoing fetal brain injury following near-term rabbit hypoxia-ischemia Dev. Neurosci. 2011, 33, 288-298
39. Xue, F.; Li, H.; Delker, S. L.; Fang, J.; Martasek, P.; Roman, L. J.; Poulos, T. L.; Silverman, R. B. Potent, highly selective, and orally bioavailable gem-difluorinated monocationic inhibitors of neuronal nitric oxide synthase J. Am. Chem. Soc. 2010, 132, 14229-14238
40. Lawton, G. R.; Ralay Ranaivo, H.; Chico, L. K.; Ji, H.; Xue, F.; Martasek, P.; Roman, L. J.; Watterson, D. M.; Silverman, R. B. Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability Bioorg. Med. Chem. 2009, 17, 2371-2380
41. Ji, H.; Delker, S. L.; Li, H.; Martasek, P.; Roman, L. J.; Poulos, T. L.; Silverman, R. B. Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives J. Med. Chem. 2010, 53, 7804-7824
42. Cheshire, D. R.; Aberg, A.; Andersson, G. M.; Andrews, G.; Beaton, H. G.; Birkinshaw, T. N.; Boughton-Smith, N.; Connolly, S.; Cook, T. R.; Cooper, A.; Cooper, S. L.; Cox, D.; Dixon, J.; Gensmantel, N.; Hamley, P. J.; Harrison, R.; Hartopp, P.; Kack, H.; Leeson, P. D.; Luker, T.; Mete, A.; Millichip, I.; Nicholls, D. J.; Pimm, A. D.; St-Gallay, S. A.; Wallace, A. V. The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS) Bioorg. Med. Chem. Lett. 2011, 21, 2468-2471
43. Garcin, E. D.; Arvai, A. S.; Rosenfeld, R. J.; Kroeger, M. D.; Crane, B. R.; Andersson, G.; Andrews, G.; Hamley, P. J.; Mallinder, P. R.; Nicholls, D. J.; St-Gallay, S. A.; Tinker, A. C.; Gensmantel, N. P.; Mete, A.; Cheshire, D. R.; Connolly, S.; Stuehr, D. J.; Aberg, A.; Wallace, A. V.; Tainer, J. A.; Getzoff, E. D. Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase Nat. Chem. Biol. 2008, 4, 700-707
44. Annedi, S. C.; Maddaford, S. P.; Ramnauth, J.; Renton, P.; Rybak, T.; Silverman, S.; Rakhit, S.; Mladenova, G.; Dove, P.; Andrews, J. S.; Zhang, D.; Porreca, F. Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl) indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine. Eur. J. Med. Chem. 2012, 55, 94-107.